サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1316562

バイオ医薬品発酵システム市場：製品、用途、エンドユーザー別-2023-2030年の世界予測

Biopharmaceutical Fermentation System Market by Product, Application, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 190 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
バイオ医薬品発酵システム市場：製品、用途、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオ医薬品発酵システムの世界市場は、2023年に156億5,000万米ドル、CAGR 7.80%で大幅な成長が予測され、2030年には265億2,000万米ドルという驚異的な規模に達する見込みです。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のバイオ医薬品発酵システム市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.バイオ医薬品発酵システムの世界市場規模および予測は？

2.予測期間中、世界のバイオ医薬品発酵システム市場を形成するCOVID-19の阻害要因と影響は？

3.バイオ医薬品発酵システムの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.バイオ医薬品発酵システムの世界市場における競争戦略は？

5.バイオ医薬品発酵システムの世界市場における技術動向と規制の枠組みは？

6.バイオ医薬品発酵システムの世界市場における主要ベンダーの市場シェアは？

7.バイオ医薬品発酵システムの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • バイオテクノロジーベースの医薬品に対する需要の増大
      • 慢性疾患の発生率の増加
      • バイオベースの生産プロセスの工業用測定および監視技術の開発
    • 抑制要因
      • 製造に伴う高コストと厳しい規制要件
    • 機会
      • 効率的でコスト効率の高い発酵システムを実現するための新しいイノベーション
      • 発酵技術のさまざまな分野での調査開発活動の増加
    • 課題
      • バイオ医薬品発酵システムの分野における知識と訓練を受けた専門家が限られている
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 バイオ医薬品発酵システム市場：製品別

  • 下流工程製品
    • クロマトグラフィーシステム
    • 消耗品と付属品
    • ろ過および分離機器
  • 上流工程製品
    • バイオリアクターまたは発酵槽
    • バッファー
    • 培地と培養の準備
    • プロセス監視システム

第7章 バイオ医薬品発酵システム市場：用途別

  • 抗生物質
  • モノクローナル抗体
  • プロバイオティクス
  • 組換えタンパク質

第8章 バイオ医薬品発酵システム市場：エンドユーザー別

  • バイオ医薬品企業
  • 受託調査機関
  • 食品業界
  • 研究開発機関

第9章 南北アメリカのバイオ医薬品発酵システム市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域のバイオ医薬品発酵システム市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカのバイオ医薬品発酵システム市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, 2022 VS 2030
  • FIGURE 3. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 7. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET DYNAMICS
  • FIGURE 9. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY FILTRATION & SEPARATION INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 11. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BIOREACTORS OR FERMENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY MEDIA & CULTURE PREPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PROCESS MONITORING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY FOOD INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY RESEARCH & DEVELOPMENT INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY DOWNSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY UPSTREAM PROCESS PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 236. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 237. BIOPHARMACEUTICAL FERMENTATION SYSTEM MARKET LICENSE & PRICING
目次
Product Code: MRR-437D45957C22

The Global Biopharmaceutical Fermentation System Market is forecasted to grow significantly, with a projected USD 15.65 billion in 2023 at a CAGR of 7.80% and expected to reach a staggering USD 26.52 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Biopharmaceutical Fermentation System Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Biopharmaceutical Fermentation System Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Downstream Process Product and Upstream Process Product. The Downstream Process Product is further studied across Chromatography Systems, Consumables & Accessories, and Filtration & Separation Instruments. The Upstream Process Product is further studied across Bioreactors or Fermenters, Buffers, Media & Culture Preparation, and Process Monitoring Systems. The Upstream Process Product is projected to witness significant market share during forecast period.

Based on Application, market is studied across Antibiotics, Monoclonal Antibodies, Probiotics, and Recombinant Proteins. The Probiotics is projected to witness significant market share during forecast period.

Based on End User, market is studied across Biopharmaceutical Companies, Contract Research Organizations, Food Industry, and Research & Development Institutes. The Research & Development Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Biopharmaceutical Fermentation System Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biopharmaceutical Fermentation System Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biopharmaceutical Fermentation System Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biopharmaceutical Fermentation System Market?

4. What is the competitive strategic window for opportunities in the Global Biopharmaceutical Fermentation System Market?

5. What are the technology trends and regulatory frameworks in the Global Biopharmaceutical Fermentation System Market?

6. What is the market share of the leading vendors in the Global Biopharmaceutical Fermentation System Market?

7. What modes and strategic moves are considered suitable for entering the Global Biopharmaceutical Fermentation System Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Biopharmaceutical Fermentation System Market, by Product, 2022 vs 2030
  • 4.3. Biopharmaceutical Fermentation System Market, by Application, 2022 vs 2030
  • 4.4. Biopharmaceutical Fermentation System Market, by End User, 2022 vs 2030
  • 4.5. Biopharmaceutical Fermentation System Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for biotech based drugs
      • 5.1.1.2. Increasing incidences of chronic diseases
      • 5.1.1.3. Development in industrial measurement and monitoring technologies for bio-based production processes
    • 5.1.2. Restraints
      • 5.1.2.1. High cost related with the manufacturing and stringent regulatory requirements
    • 5.1.3. Opportunities
      • 5.1.3.1. New innovations to make efficient and cost-effective fermentation systems
      • 5.1.3.2. Increasing research and developmental activities in different fields of fermentation technology
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and trained professionals in the field for biopharmaceutical fermentation systems
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Biopharmaceutical Fermentation System Market, by Product

  • 6.1. Introduction
  • 6.2. Downstream Process Product
    • 6.2.1. Chromatography Systems
    • 6.2.2. Consumables & Accessories
    • 6.2.3. Filtration & Separation Instruments
  • 6.3. Upstream Process Product
    • 6.3.1. Bioreactors or Fermenters
    • 6.3.2. Buffers
    • 6.3.3. Media & Culture Preparation
    • 6.3.4. Process Monitoring Systems

7. Biopharmaceutical Fermentation System Market, by Application

  • 7.1. Introduction
  • 7.2. Antibiotics
  • 7.3. Monoclonal Antibodies
  • 7.4. Probiotics
  • 7.5. Recombinant Proteins

8. Biopharmaceutical Fermentation System Market, by End User

  • 8.1. Introduction
  • 8.2. Biopharmaceutical Companies
  • 8.3. Contract Research Organizations
  • 8.4. Food Industry
  • 8.5. Research & Development Institutes

9. Americas Biopharmaceutical Fermentation System Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biopharmaceutical Fermentation System Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Biopharmaceutical Fermentation System Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing